RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Inhaled Pharmaceutical Product Development Perspectives:
Challenges and Opportunities describes methods and procedures for consideration
when developing inhaled pharmaceuticals, while commenting on product
development strategies and their suitability to support regulatory submission.
It bridges the gap between the aspirations of scientists invested in new
technology development and the requirements that must be met for any new
product.
The book brings together emerging analytical and inhalation
technologies, providing perspectives that illuminate formulation and device
design, development, regulatory compliance, and practice. Focusing on
underlying scientific and technical principles known to be acceptable from the
current regulatory perspective, this monograph will remain useful as a
high-level guide to inhaled product development for the foreseeable future.
RTI’s mission is to improve the human condition by turning knowledge into practice. As an independent, scientific research institute, we share our findings openly - through RTI Press, other peer-reviewed publications, and media – in line with scientific standards. Sharing our evidence-based results ensures the scientific community can build on the knowledge and that our findings benefit as many people as possible.